| dc.contributor.author | Osmanbasoglu, O. A. | |
| dc.contributor.author | Ozkaya, H. M. | |
| dc.contributor.author | Demirok, A. | |
| dc.contributor.author | Ozkaya, A. | |
| dc.contributor.author | Alkin, Z. | |
| dc.date.accessioned | 2021-03-05T10:18:47Z | |
| dc.date.available | 2021-03-05T10:18:47Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Ozkaya A., Alkin Z., Osmanbasoglu O. A. , Ozkaya H. M. , Demirok A., "Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes", JOURNAL FRANCAIS D OPHTALMOLOGIE, cilt.37, ss.280-287, 2014 | |
| dc.identifier.issn | 0181-5512 | |
| dc.identifier.other | av_a265f9bc-56ec-43ac-9d0f-284fae34cab5 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/108776 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jfo.2013.08.006 | |
| dc.description.abstract | Purpose. - To evaluate the efficiency fo intravitreal ranibizumb for the treatment of neovascular age-related macular degeneration (nAMD) patients with a visual acuity (VA) of >= 20/40 and to investigate the predictive factors for visual outcomes. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp | |
| dc.subject | OFTALMOLOJİ | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Cerrahi Tıp Bilimleri | |
| dc.subject | Göz Hastalıkları ve Cerrahisi | |
| dc.title | Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL FRANCAIS D OPHTALMOLOGIE | |
| dc.contributor.department | Beyoglu Eye Training & Res Hosp , , | |
| dc.identifier.volume | 37 | |
| dc.identifier.issue | 4 | |
| dc.identifier.startpage | 280 | |
| dc.identifier.endpage | 287 | |
| dc.contributor.firstauthorID | 213948 | |
